The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia

Allogeneic placental-derived ASC may provide an off-the-shelf supply of therapeutic cells that would need no histocompatible tissue matching and be potentially less expensive and considerably more convenient than BM or adipose-derived MSC.